We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Depression Confirmed as Osteoporosis Risk Factor

By LabMedica International staff writers
Posted on 22 Nov 2009
A recently published review article summarized studies relating clinical depression and osteoporosis and concluded that a clear connection exists between the two.

Osteoporosis is the most widespread degenerative disease in the developed world, afflicting about 33% of women and 20% of men in the over 50 age group. In an endeavor to better understand risk factors for the syndrome, investigators at the Hebrew University of Jerusalem (Israel) reviewed research articles that related loss of bone mass, which characterizes osteoporosis, to evidence of clinical depression.

Their findings, based on the evaluation of 23 research projects conducted in eight countries that compared bone density among 2,327 people suffering from depression against 21,141 nondepressed individuals were published in the September 2009 issue of the journal Biological Psychiatry. The results showed that overall, depressed individuals displayed lower bone mass density than nondepressed subjects. The association between depression and bone mass density was similar in the spine, hip, and forearm. It was stronger in women than in men, and in premenopausal than postmenopausal women. Only women individually diagnosed for major depression by a psychiatrist displayed significantly lower bone mass density; women diagnosed by self-rating questionnaires did not. Depressed subjects had increased urinary levels of bone breakdown markers as compared to their nondepressed counterparts.

Based on these findings the authors concluded that, "All individuals psychiatrically diagnosed with major depression are at risk for developing osteoporosis, with depressed young women showing the highest risk. These patients should be periodically evaluated for progression of bone loss and signs of osteoporosis, allowing the use of antiosteoporotic prophylactic and therapeutic treatments."

Related Links:
Hebrew University of Jerusalem




New
Gold Member
Thyroid Stimulating Hormone Assay
TSH EIA 96 Test
Automated Blood Typing System
IH-500 NEXT
New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
New
Sulfidoleukotrienes (sLT) Assay
CAST ELISA

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma

New Method Simplifies Preparation of Tumor Genomic DNA Libraries